Phase 3 Cirrhosis Clinical Trials
13 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc.762 enrolled291 locationsNCT06419374
Recruiting
Phase 3
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Liver Cirrhosis
King's College London300 enrolled23 locationsNCT06461208
Recruiting
Phase 3
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
Decompensated Cirrhosis and Ascites
Aleksander Krag240 enrolled12 locationsNCT05056220
Recruiting
Phase 2Phase 3
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Hepatocellular CarcinomaCirrhosis
Inova Health Care Services12 enrolled2 locationsNCT06007846
Recruiting
Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma471 enrolled32 locationsNCT05201404
Recruiting
Phase 3
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
Liver CirrhosisSarcopenia in Liver CirrhosisRefractory Ascites in Patients with Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies72 enrolled2 locationsNCT06814626
Recruiting
Phase 2Phase 3
Faecal Microbiota Transplantation for Liver Cirrhosis
Liver Cirrhosis
University of Aarhus220 enrolled1 locationNCT04932577
Recruiting
Phase 3
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
Diabetes MellitusCirrhosisOncologic Disorders
Consorcio Centro de Investigación Biomédica en Red (CIBER)1,000 enrolled6 locationsNCT05769868
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Alcoholic Cirrhosis
Pharmicell Co., Ltd.200 enrolled11 locationsNCT04689152
Completed
Phase 3
The impact of continuous terlipressin infusion on complications of end-stage liver disease
CirrhosisAscitesMalnutrition+2 more
Austin Health30 enrolled1 locationACTRN12619000891123
Recruiting
Phase 3
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
Liver CirrhosisMuscle Cramps
Sherief Abd-Elsalam100 enrolled1 locationNCT02423395
Completed
Phase 3
The Impact of Low Testosterone Levels on Men with Liver Failure, and the Efficacy of Testosterone Therapy
Low testosteroneCirrhosis
The University of Melbourne100 enrolled1 locationACTRN12614000526673
Completed
Phase 3
Oral Supplementation with Taurine for Patients with Cirrhosis and Muscle Cramps
Hepatic CirrhosisMuscle Cramps
Royal Prince Alfred Hospital50 enrolled1 locationACTRN12612000289819